Spironolactone and canrenoate: Different antialdosteronic diuretic agents
Jorge J. Gumucio, Paolo Gentilini – 1 May 1991 – Plasma levels of canrenone and androgen receptoractive materials (ARM) were determined during long‐term oral K‐canrenoate or spironolactone therapy in cirrhotics with chronic recurrent ascites. Mean plasma canrenone level was approximately 3 times higher under K‐canrenoate than under spironolactone treatment; moreover, the levels were not dose related. Either type of treatment did not affect plasma aldosterone and testosterone concentrations.